These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 30391371)

  • 1. Changes in serum KL-6 levels are associated with the development of chronic lung allograft dysfunction in lung transplant recipients.
    Bessa V; Bonella F; Ohshimo S; Weinreich G; Kleibrink B; Costabel U; Aigner C; Kamler M; Taube C; Sommerwerck U
    Transpl Immunol; 2019 Feb; 52():40-44. PubMed ID: 30391371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of serum KL-6 level for detecting patients with restrictive allograft syndrome after lung transplantation.
    Berastegui C; Gómez-Ollés S; Mendoza-Valderrey A; Pereira-Veiga T; Culebras M; Monforte V; Saez B; López-Meseguer M; Sintes-Permanyer H; Ruiz de Miguel V; Bravo C; Sacanell J; Ramon MA; Romero L; Deu M; Román A
    PLoS One; 2020; 15(1):e0226488. PubMed ID: 31929536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of serum KL-6 versus bronchoalveolar lavage neutrophilia for the diagnosis of bronchiolitis obliterans in lung transplantation.
    Ohshimo S; Bonella F; Sommerwerck U; Teschler H; Kamler M; Jakob HG; Kohno N; Guzman J; Costabel U
    J Heart Lung Transplant; 2011 Dec; 30(12):1374-80. PubMed ID: 21871820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and impact of chronic lung allograft dysfunction after lung transplantation - single-center 14-year experience.
    Nykänen A; Raivio P; Peräkylä L; Stark C; Huuskonen A; Lemström K; Halme M; Hämmäinen P
    Scand Cardiovasc J; 2020 Jun; 54(3):192-199. PubMed ID: 32148103
    [No Abstract]   [Full Text] [Related]  

  • 5. Self-reactive antibodies associated with bronchiolitis obliterans syndrome subtype of chronic lung allograft dysfunction.
    Kaza V; Zhu C; Terada LS; Wang L; Torres F; Bollineni S; Mohanka M; Banga A; Joerns J; Mohanakumar T; Li QZ
    Hum Immunol; 2021 Jan; 82(1):25-35. PubMed ID: 33129576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative chest CT for subtyping chronic lung allograft dysfunction and its association with survival.
    Horie M; Salazar P; Saito T; Binnie M; Brock K; Yasufuku K; Azad S; Keshavjee S; Martinu T; Paul N
    Clin Transplant; 2018 May; 32(5):e13233. PubMed ID: 29637624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum KL-6 as a marker for bronchiolitis obliterans syndrome after lung transplantation.
    Walter JN; Fan LL; Bag R; Zhang H; Doan M; Mallory GB; Elidemir O
    Transplantation; 2006 Sep; 82(5):709-11. PubMed ID: 16969297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum KL-6 level and the development of bronchiolitis obliterans syndrome in lung transplant recipients.
    Haberman B; Doan ML; Smith EO; Schecter MG; Mallory GB; Elidemir O
    Pediatr Transplant; 2010 Nov; 14(7):903-8. PubMed ID: 20667031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. De Novo DQ Donor-Specific Antibodies Are Associated with Chronic Lung Allograft Dysfunction after Lung Transplantation.
    Tikkanen JM; Singer LG; Kim SJ; Li Y; Binnie M; Chaparro C; Chow CW; Martinu T; Azad S; Keshavjee S; Tinckam K
    Am J Respir Crit Care Med; 2016 Sep; 194(5):596-606. PubMed ID: 26967790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BALF cytokines in different phenotypes of chronic lung allograft dysfunction in lung transplant patients.
    Berastegui C; Gómez-Ollés S; Sánchez-Vidaurre S; Culebras M; Monforte V; López-Meseguer M; Bravo C; Ramon MA; Romero L; Sole J; Cruz MJ; Román A
    Clin Transplant; 2017 Mar; 31(3):. PubMed ID: 28008659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of early pulmonary function changes after onset of chronic lung allograft dysfunction.
    Todd JL; Neely ML; Finlen Copeland CA; Frankel CW; Reynolds JM; Palmer SM
    J Heart Lung Transplant; 2019 Feb; 38(2):184-193. PubMed ID: 30466803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restrictive allograft syndrome (RAS): a novel form of chronic lung allograft dysfunction.
    Sato M; Waddell TK; Wagnetz U; Roberts HC; Hwang DM; Haroon A; Wagnetz D; Chaparro C; Singer LG; Hutcheon MA; Keshavjee S
    J Heart Lung Transplant; 2011 Jul; 30(7):735-42. PubMed ID: 21419659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time-dependent changes in the risk of death in pure bronchiolitis obliterans syndrome (BOS).
    Sato M; Ohmori-Matsuda K; Saito T; Matsuda Y; Hwang DM; Waddell TK; Singer LG; Keshavjee S
    J Heart Lung Transplant; 2013 May; 32(5):484-91. PubMed ID: 23433813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase-resolved Functional Lung (PREFUL) MRI-derived Ventilation and Perfusion Parameters Predict Future Lung Transplant Loss.
    Vogel-Claussen J; Kaireit TF; Voskrebenzev A; Klimeš F; Glandorf J; Behrendt L; Gutberlet M; Korz C; Speth M; Welte T; Wacker F; Gottlieb J
    Radiology; 2023 May; 307(4):e221958. PubMed ID: 37070996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lung microbiota predict chronic rejection in healthy lung transplant recipients: a prospective cohort study.
    Combs MP; Wheeler DS; Luth JE; Falkowski NR; Walker NM; Erb-Downward JR; Lama VN; Dickson RP
    Lancet Respir Med; 2021 Jun; 9(6):601-612. PubMed ID: 33460570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal lung function measurements in single lung transplant recipients with chronic lung allograft dysfunction.
    Leuschner G; Lauseker M; Howanietz AS; Milger K; Veit T; Munker D; Schneider C; Weig T; Michel S; Barton J; Meiser B; Dinkel J; Neurohr C; Behr J; Kneidinger N
    J Heart Lung Transplant; 2020 Nov; 39(11):1270-1278. PubMed ID: 32917480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-Term Off-Line Extracorporeal Photochemotherapy in Patients with Chronic Lung Allograft Rejection Not Responsive to Conventional Treatment: A 10-Year Single-Centre Analysis.
    Del Fante C; Scudeller L; Oggionni T; Viarengo G; Cemmi F; Morosini M; Cascina A; Meloni F; Perotti C
    Respiration; 2015; 90(2):118-28. PubMed ID: 26112178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation and Refinement of Chronic Lung Allograft Dysfunction Phenotypes in Bilateral and Single Lung Recipients.
    DerHovanessian A; Todd JL; Zhang A; Li N; Mayalall A; Finlen Copeland CA; Shino M; Pavlisko EN; Wallace WD; Gregson A; Ross DJ; Saggar R; Lynch JP; Belperio J; Snyder LD; Palmer SM; Weigt SS
    Ann Am Thorac Soc; 2016 May; 13(5):627-35. PubMed ID: 27144793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose computed tomography volumetry for subtyping chronic lung allograft dysfunction.
    Saito T; Horie M; Sato M; Nakajima D; Shoushtarizadeh H; Binnie M; Azad S; Hwang DM; Machuca TN; Waddell TK; Singer LG; Cypel M; Liu M; Paul NS; Keshavjee S
    J Heart Lung Transplant; 2016 Jan; 35(1):59-66. PubMed ID: 26342441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of HMG CoA reductase inhibitors on the development of chronic lung allograft dysfunction.
    Szczepanik A; Hulbert A; Lee HJ; Benedetti C; Snyder L; Byrns J
    Clin Transplant; 2018 Jan; 32(1):. PubMed ID: 29151274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.